These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21654877)

  • 1. Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.
    Lee G; Gardner BK; Elashoff DA; Purcell CM; Sandha HS; Mao JT; Krysan K; Lee JM; Dubinett SM
    Am J Transl Res; 2011 May; 3(3):226-33. PubMed ID: 21654877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.
    Yee J; Sadar MD; Sin DD; Kuzyk M; Xing L; Kondra J; McWilliams A; Man SF; Lam S
    J Clin Oncol; 2009 Jun; 27(17):2787-92. PubMed ID: 19414677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
    Schenk BI; Petersen F; Flad HD; Brandt E
    J Immunol; 2002 Sep; 169(5):2602-10. PubMed ID: 12193731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
    Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF
    Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L; Petersen F; Flad HD; Brandt E
    J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III.
    Deutsch V; Bitan M; Friedmann Y; Eldor A; Vlodavsky I
    Br J Haematol; 2000 Dec; 111(4):1180-9. PubMed ID: 11167759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
    Tai PK; Liao JF; Hossler PA; Castor CW; Carter-Su C
    J Biol Chem; 1992 Sep; 267(27):19579-86. PubMed ID: 1527075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
    Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
    Ehlert JE; Gerdes J; Flad HD; Brandt E
    J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD; Baggiolini M; Walz A
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
    Schiemann F; Grimm TA; Hoch J; Gross R; Lindner B; Petersen F; Bulfone-Paus S; Brandt E
    Blood; 2006 Mar; 107(6):2234-42. PubMed ID: 16317101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
    J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E; Van Damme J; Flad HD
    Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
    Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
    J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
    Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP
    Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG; Lazar JB; Johnson PH; Edwards BF
    J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
    J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera.
    Weiss JJ; Meyers S; Castor CW; Donakowski C; Anderson B
    Clin Chim Acta; 1980 Dec; 108(3):425-33. PubMed ID: 7471473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
    Walz A; Baggiolini M
    J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.